Assisted reproductive technologies in Latin America: the Latin American Registry, 2019.


Journal

JBRA assisted reproduction
ISSN: 1518-0557
Titre abrégé: JBRA Assist Reprod
Pays: Brazil
ID NLM: 101684552

Informations de publication

Date de publication:
09 11 2022
Historique:
pubmed: 14 9 2022
medline: 15 11 2022
entrez: 13 9 2022
Statut: epublish

Résumé

What was the utilization, effectiveness and safety of assisted reproductive technology (ART) in Latin America during 2019? This was a retrospective collection of multinational data on ART performed at 196 institutions from 15 countries. A total of 106,918 initiated cycles, 18,133 deliveries and 21,096 births were reported. ART utilization was 24-558 cycles per million inhabitants. Women aged ≥40 years represented 32.9% of fresh IVF and intracytoplasmic sperm injection (ICSI) cycles. After removing freeze-all cycles, the delivery rate per oocyte retrieval was 17.3% for ICSI and 19.5% for IVF. Overall, single-embryo transfer (SET) represented 36.2% of fresh transfers, with a 19.5% delivery rate per transfer, increasing to 30.7% for elective SET and 32.7% for blastocyst elective SET (eSET). The delivery rate for double-embryo transfers (DET) was 27.8%, increasing to 37.1% after elective DET. This 6.4% increment in deliveries between eSET and elective DET resulted in a 12-fold increase in twin births. Furthermore, overall perinatal mortality was more than two-fold higher for twin compared with singleton deliveries. The delivery rate for frozen-thawed SET reached 28.1%, most being blastocyst transfers. Of all births, 72.3% were singletons, 26.4% twins and 1.3% triplets and higher multiples. Preterm deliveries reached 14.3% for singletons and 58.1% for twins. Perinatal mortality was 7.4‰ in singletons, 17.2‰ for twins and 62.9‰ for triplets or higher. The number of initiated cycles has slowly increased in countries with laws or regulations facilitating access. FET cycles predominate and blastocyst SET are also increasing. The data show that, especially in young women and oocyte recipients, when there is more than one blastocyst for transfer, eSET should be the rule.

Identifiants

pubmed: 36098475
doi: 10.5935/1518-0557.20220034
pmc: PMC9635608
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

637-658

Auteurs

Fernando Zegers-Hochschild (F)

Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.
Program of Ethics and Public Policies in Human Reproduction, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.

Javier A Crosby (JA)

Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.

Carolina Musri (C)

Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.

Maria do Carmo Borges de Souza (MDCB)

Fertipraxis, Barra da Tijuca Rio de Janeiro, Brazil.

A Gustavo Martinez (AG)

Fertilis, San Isidro Provincia de Buenos Aires, Argentina.

Adelino Amaral Silva (AA)

Genesis-Centro de Assistência em Reprodução Humana, SHLS cj L, Brasília, Brazil.

José María Mojarra (JM)

Hospital CIMA Hermosillo, Col. Proyecto Rio Sonora C.P., Hermosillo Sonora 83280, Mexico.

Diego Masoli (D)

Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.

Natalia Posada (N)

INSER, Sector El Poblado Medellín, Colombia.

Latin American Network Of Assisted Reproduction (LANOA)

Latin American Network of Assisted Reproduction (REDLARA) Montevideo, Uruguay.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH